Patents by Inventor David E. Kindrachuk

David E. Kindrachuk has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine H4 receptor
    Patent number: 9365548
    Abstract: Benzoimidazol-2-yl pyrimidines and pyrazines, pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by H4 receptor activity, including allergy, asthma, autoimmune diseases, and pruritis.
    Type: Grant
    Filed: January 28, 2015
    Date of Patent: June 14, 2016
    Assignee: Janssen Pharmaceutica NV
    Inventors: James P. Edwards, David E. Kindrachuk, Christopher M. Mapes, Daniel J. Pippel, Jennifer D. Venable
  • Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine H4 receptor
    Publication number: 20150148361
    Abstract: Benzoimidazol-2-yl pyrimidines and pyrazines, pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by H4 receptor activity, including allergy, asthma, autoimmune diseases, and pruritis.
    Type: Application
    Filed: January 28, 2015
    Publication date: May 28, 2015
    Inventors: James P. Edwards, David E. Kindrachuk, Christopher M. Mapes, Daniel J. Pippel, Jennifer D. Venable
  • Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine Hreceptor
    Patent number: 8962644
    Abstract: Benzoimidazol-2-yl pyrimidines and pyrazines, pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by H4 receptor activity, including allergy, asthma, autoimmune diseases, and pruritis.
    Type: Grant
    Filed: October 11, 2013
    Date of Patent: February 24, 2015
    Assignee: Janssen Pharmaceutica, NV
    Inventors: James P. Edwards, David E. Kindrachuk, Christopher M. Mapes, Daniel J. Pippel, Jennifer D. Venable
  • Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine H4 receptor
    Publication number: 20140038995
    Abstract: Benzoimidazol-2-yl pyrimidines and pyrazines, pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by H4 receptor activity, including allergy, asthma, autoimmune diseases, and pruritis.
    Type: Application
    Filed: October 11, 2013
    Publication date: February 6, 2014
    Applicant: Janssen Pharmaceutica NV
    Inventors: James P. Edwards, David E. Kindrachuk, Christopher M. Mapes, Daniel J. Pippel, Jennifer D. Venable
  • Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine Hreceptor
    Patent number: 8598189
    Abstract: Benzoimidazol-2-yl pyrimidines and pyrazines, pharmaceutical compositions and methods for H4 receptor activity modulation and for the treatment of disease states, disorders, and conditions mediated by H4 receptor activity, including allergy, asthma, autoimmune diseases, and pruritis.
    Type: Grant
    Filed: November 14, 2012
    Date of Patent: December 3, 2013
    Assignee: Janssen Pharmaceutica NV
    Inventors: James P. Edwards, David E. Kindrachuk, Christopher M. Mapes, Daniel J. Pippel, Jennifer D. Venable
  • Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine Hreceptor
    Patent number: 8343989
    Abstract: Benzoimidazol-2-yl pyrimidines and pyrazines, pharmaceutical compositions and methods for H4 receptor activity modulation and for the treatment of disease states, disorders, and conditions mediated by H4 receptor activity, including allergy, asthma, autoimmune diseases, and pruritis.
    Type: Grant
    Filed: June 16, 2010
    Date of Patent: January 1, 2013
    Assignee: Janssen Pharmaceutica NV
    Inventors: James P. Edwards, David E. Kindrachuk, Christopher M. Mapes, Daniel J. Pippel, Jennifer D. Venable
  • Bicyclic heteroaryl-substituted imidazoles as modulators of the histamine Hreceptor
    Patent number: 8084466
    Abstract: Bicyclic heteroaryl-substituted imidazole compounds are described, which are useful as H4 receptor modulators. Such compounds may be used in pharmaceutical compositions and methods for the modulation of histamine H4 receptor activity and for the treatment of disease states, disorders, and conditions mediated by H4 receptor activity, such as allergy, asthma, autoimmune diseases, and pruritis.
    Type: Grant
    Filed: December 16, 2008
    Date of Patent: December 27, 2011
    Assignee: Janssen Pharmaceutica NV
    Inventors: David E. Kindrachuk, Jennifer D. Venable
  • Imidazole compounds
    Patent number: 8039498
    Abstract: Imidazole compounds, compositions, and methods of using them in leukocyte recruitment inhibition, in modulating H4 receptor expression, and in treating conditions such as inflammation, H4 receptor-mediated conditions, and related conditions.
    Type: Grant
    Filed: June 29, 2007
    Date of Patent: October 18, 2011
    Assignee: Janssen Pharmaceutica NV
    Inventors: Daniel J. Buzard, James P. Edwards, David E. Kindrachuk, Jennifer D. Venable
  • Imidazole compounds
    Patent number: 8017600
    Abstract: Imidazole compounds, compositions, and methods of using them in leukocyte recruitment inhibition, in modulating H4 receptor expression, and in treating conditions such as inflammation, H4 receptor-mediated conditions, and related conditions.
    Type: Grant
    Filed: June 9, 2010
    Date of Patent: September 13, 2011
    Assignee: Janssen Pharmaceutica NV
    Inventors: Daniel J. Buzard, James P. Edwards, David E. Kindrachuk, Jennifer D. Venable
  • Imidazole compounds
    Patent number: 8017639
    Abstract: Imidazole compounds, compositions, and methods of using them in leukocyte recruitment inhibition, in modulating H4 receptor expression, and in treating conditions such as inflammation, H4 receptor-mediated conditions, and related conditions.
    Type: Grant
    Filed: June 4, 2010
    Date of Patent: September 13, 2011
    Assignee: Janssen Pharmaceutica NV
    Inventors: Daniel J. Buzard, James P. Edwards, David E. Kindrachuk, Jennifer D. Venable
  • Imidazole compounds
    Patent number: 7956057
    Abstract: Imidazole compounds, compositions, and methods of using them in leukocyte recruitment inhibition, in modulating H4 receptor expression, and in treating conditions such as inflammation, H4 receptor-mediated conditions, and related conditions.
    Type: Grant
    Filed: February 8, 2007
    Date of Patent: June 7, 2011
    Assignee: Janssen Pharmaceutica NV
    Inventors: Daniel J. Buzard, James P. Edwards, David E. Kindrachuk, Jennifer D. Venable
  • Imidazole compounds
    Patent number: 7956071
    Abstract: Imidazole compounds, compositions, and methods of using them in leukocyte recruitment inhibition, in modulating H4 receptor expression, and in treating conditions such as inflammation, H4 receptor-mediated conditions, and related conditions.
    Type: Grant
    Filed: February 8, 2007
    Date of Patent: June 7, 2011
    Assignee: Janssen Pharmaceutica NV
    Inventors: Daniel J. Buzard, James P. Edwards, David E. Kindrachuk, Jennifer D. Venable
  • Imidazole compounds
    Patent number: 7956066
    Abstract: Imidazole compounds, compositions, and methods of using them in leukocyte recruitment inhibition, in modulating H4 receptor expression, and in treating conditions such as inflammation, H4 receptor-mediated conditions, and related conditions.
    Type: Grant
    Filed: February 8, 2007
    Date of Patent: June 7, 2011
    Assignee: Janssen Pharmaceutica NV
    Inventors: Daniel J. Buzard, James P. Edwards, David E. Kindrachuk, Jennifer D. Venable
  • Imidazole compounds
    Patent number: 7951808
    Abstract: Imidazole compounds, compositions, and methods of using them in leukocyte recruitment inhibition, in modulating H4 receptor expression, and in treating conditions such as inflammation, H4 receptor-mediated conditions, and related conditions.
    Type: Grant
    Filed: February 8, 2007
    Date of Patent: May 31, 2011
    Assignee: Janssen Pharmaceutica NV
    Inventors: Daniel J. Buzard, James P. Edwards, David E. Kindrachuk, Jennifer D. Venable
  • Imidazole compounds
    Patent number: 7928131
    Abstract: Imidazole compounds, compositions, and methods of using them in leukocyte recruitment inhibition, in modulating H4 receptor expression, and in treating conditions such as inflammation, H4 receptor-mediated conditions, and related conditions.
    Type: Grant
    Filed: February 8, 2007
    Date of Patent: April 19, 2011
    Assignee: Janssen Pharmaceutica NV
    Inventors: Daniel J. Buzard, James P. Edwards, David E. Kindrachuk, Jennifer D. Venable
  • IMIDAZOLE COMPOUNDS
    Publication number: 20100261899
    Abstract: Imidazole compounds, compositions, and methods of using them in leukocyte recruitment inhibition, in modulating H4 receptor expression, and in treating conditions such as inflammation, H4 receptor-mediated conditions, and related conditions.
    Type: Application
    Filed: June 9, 2010
    Publication date: October 14, 2010
    Inventors: Daniel J. Buzard, James P. Edwards, David E. Kindrachuk, Jennifer D. Venable
  • IMIDAZOLE COMPOUNDS
    Publication number: 20100261898
    Abstract: Imidazole compounds, compositions, and methods of using them in leukocyte recruitment inhibition, in modulating H4 receptor expression, and in treating conditions such as inflammation, H4 receptor-mediated conditions, and related conditions.
    Type: Application
    Filed: June 4, 2010
    Publication date: October 14, 2010
    Inventors: Daniel J. BUZARD, James P. Edwards, David E. Kindrachuk, Jennifer D. Venable
  • BENZOIMIDAZOL-2-YL PYRIMIDINES AND PYRAZINES AS MODULATORS OF THE HISTAMINE H4 RECEPTOR
    Publication number: 20100256373
    Abstract: Benzoimidazol-2-yl pyrimidines and pyrazines, pharmaceutical compositions and methods for H4 receptor activity modulation and for the treatment of disease states, disorders, and conditions mediated by H4 receptor activity, including allergy, asthma, autoimmune diseases, and pruritis.
    Type: Application
    Filed: June 16, 2010
    Publication date: October 7, 2010
    Inventors: James P. EDWARDS, David E. KINDRACHUK, Christopher M. MAPES, Daniel J. PIPPEL, Jennifer D. VENABLE
  • Benzoimidazole compounds
    Patent number: 7723526
    Abstract: Benzoimidazole compounds, compositions, and methods of using them in leukocyte recruitment inhibition, in modulating H4 receptor, and in treating conditions such as inflammation, H4 receptor-mediated conditions, and related conditions.
    Type: Grant
    Filed: August 26, 2008
    Date of Patent: May 25, 2010
    Assignee: Janssen Pharmaceutica NV
    Inventors: James P. Edwards, Michael D. Hack, David E. Kindrachuk, Jennifer D. Venable
  • Benzoimidazole compounds
    Patent number: 7723359
    Abstract: Benzoimidazole compounds, compositions, and methods of using them in leukocyte recruitment inhibition, in modulating H4 receptor, and in treating conditions such as inflammation, H4 receptor-mediated conditions, and related conditions.
    Type: Grant
    Filed: August 26, 2008
    Date of Patent: May 25, 2010
    Assignee: Janssen Pharmaceutica NV
    Inventors: James P. Edwards, Michael D. Hack, David E. Kindrachuk, Jennifer D. Venable